SCHEMBL18616630

SCHEMBL18616630

COc1cc(-c2cnc(N)c(C(N)=O)c2)ccc1CO

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 5/20 0.57
▸ CHEK1 O14757 2/20 0.57
▸ FYN P06241 7/20 0.55
▸ PIK3CB P42338 1/20 0.53
▸ AXL P30530 2/20 0.53
▸ MERTK Q12866 2/20 0.53
▸ NEK2 P51955 2/20 0.47
▸ MKNK1 Q9BUB5 1/20 0.45
▸ MKNK2 Q9HBH9 1/20 0.45
▸ TGFBR1 P36897 1/20 0.44
▸ MAP3K11 Q16584 1/20 0.43
▸ PDCD1 Q15116 1/20 0.43
▸ CD274 Q9NZQ7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18616325 0.87 CHEK2 (0.68) CHEK2CHEK1FYNPIK3CBAXL
SCHEMBL18615580 0.75 PIK3CB (0.55) CHEK2CHEK1FYNPIK3CBAXL
SCHEMBL23249740 0.74 PDCD1 (0.52) CHEK2CHEK1FYNAXLMERTK
SCHEMBL18615844 0.73 PIK3CB (0.67) CHEK2FYNPIK3CBMKNK1TGFBR1
SCHEMBL18617207 0.72 PIK3CB (0.58) CHEK2FYNPIK3CBAXLMERTK
SCHEMBL1478747 0.71 CHEK2 (0.61) CHEK2CHEK1FYNPIK3CBAXL
SCHEMBL18617182 0.71 CHEK2 (0.64) CHEK2CHEK1FYNPIK3CBMKNK1
SCHEMBL18615835 0.71 CHEK2 (0.64) CHEK2FYNPIK3CBMKNK1MKNK2
SCHEMBL18613347 0.71 FYN (1.00) CHEK2CHEK1FYNTGFBR1
SCHEMBL30521707 0.71 FYN (1.00) CHEK2CHEK1FYNTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3344613-B1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG A SOCIO HOLDINGS CO LTD (KR) 2020-03-04 — — EP disclosed
WO-2017039331-A1 HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2017-03-09 — — WO disclosed
Send feedback